Healthtech startup has secured $11 million in a Series A funding round, with MassMutual Ventures leading the investment. Other notable participants in the funding round include, Tanglin Venture Partners, and Endiya Partners. This injection of capital is aimed at bolstering’s product offerings, establishing an offline presence, and further advancing their research and development efforts in the realm of diabetes management.

A staggering 100 million individuals grapple with Type 2 diabetes, while an additional 130 million teeter on the precipice of pre-diabetes. steps in with its comprehensive diabetes care program, which integrates cutting-edge devices such as continuous glucose monitors, fitness trackers, and various health diagnostics. The platform also connects users with diabetes specialists and health coaches.

Users leverage to monitor how their lifestyle choices impact their glucose levels in real-time. They receive personalized guidance encompassing fitness, nutrition, and sleep. Remarkably, users have witnessed an average 2% reduction in HbA1c levels after just three months. HbA1c measures the average blood sugar level over two to three months.

Madan Somasundaram, co-founder and CEO of, expressed the intent to utilize this investment to enhance their technology and expand their reach across India, ultimately empowering more individuals to take control of their diabetes and improve their health.

Anvesh Ramineni, managing partner at MassMutual Ventures, expressed enthusiasm about’s innovative approach to diabetes management, combining hardware, software, and analytics to deliver personalized programs that foster lasting behavioral change for improved health outcomes.

Since its founding in 2021, has shown impressive growth, with eightfold expansion in paid subscribers over the past 18 months, now serving over 25,000 users. The founding team, consisting of Madan Somasundaram and Shivtosh Kumar, boasts executives with experience in prominent companies, including Walmart Labs, Curefit, Dailyhunt, Flipkart, Myntra, and Samsung is creating a buzz in the healthtech world! They recently secured a whopping  $11 million in funding to expand their diabetes management program and help more people improve their health. Best wishes to the team! 

~ Dr Shishir Gupta founder & CEO of StartupLanes 

About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.

Startups looking for funding may apply through StartupLanes Funding Application.

Angel Investors Register Free to explore exciting startup investment opportunities.